Prevention of Hepatitis A Through Active or Passive Immunization

Recommendations of the Advisory Committee on Immunization Practices (ACIP)

From U.S. Centers for Disease Control and Prevention

December 27, 1996

Summary

This report provides recommendations for use of the newly licensed hepatitis A vaccines (HAVRIX,® manufactured by SmithKline Beecham Biologicals, and VAQTA,® manufactured by Merck & Company, Inc.) in persons > 2 years of age and updates previous recommendations for use of immune globulin (IG) for protection against hepatitis A (superseding MMWR 1990;39[No. RR-2]:1-5). For preexposure protection, hepatitis A vaccine can now be used instead of IG in many circumstances; for postexposure prophylaxis, the recommendations for IG use are unchanged.

Back | Next
Table of Contents

This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication Morbidity and Mortality Weekly Report.

My Health Tracker

Assess Your Risk for HIV

U.S. ASO Finder

Find a Therapist

What Really Fuels the HIV/AIDS Epidemic in Black America?

Top 10 HIV/AIDS-Related Clinical Developments of 2011

Ten HIV/AIDS Stories that Defined 2011

Where It Came From: A Blog Entry by Brooke Davidoff

Tennessee Senator: It's Virtually Impossible for Heterosexuals to Contract HIV From Sex: A Blog Entry by Kellee Terrell

More >>

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.